Natera
Erik Spickard, Ph.D., is an accomplished scientist with a focus on molecular biology research, currently serving as a Scientist R&D at Natera since November 2020, specializing in circulating tumor DNA testing for cancer treatment monitoring. Prior to this, Erik worked as a Senior Scientific Moderator at Viral Feedback, providing data-driven analysis of COVID-19-related information. Erik's academic background includes a Ph.D. from UC Santa Barbara in Molecular, Cellular, and Developmental Biology, alongside a BS in Biotechnology and Animal Science from the University of California, Davis. Previous positions also include research roles at Hologic, Molecular Response, and UC Davis Medical Center, where Erik contributed to various molecular and clinical research projects.
This person is not in any teams
This person is not in any offices
Natera
25 followers
Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology. Where some set out to build a test, they set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment.